High-performance liquid chromatography (HPLC) is the gold standard for peptide purification. This guide covers method development from column selection through gradient optimization to fraction collection strategies.

1. Fundamental Principles

Reversed-Phase HPLC (RP-HPLC)

RP-HPLC separates peptides based on hydrophobicity. The stationary phase is nonpolar (C18, C8), and the mobile phase is polar (water/acetonitrile with ion-pairing agents).

Retention mechanism: Hydrophobic interactions between peptide side chains and alkyl chains on silica surface. Retention increases with:

• Peptide length (more hydrophobic residues)
• Amino acid composition (Leu, Ile, Phe > Ala > Gly)
• Lower organic solvent concentration
• Higher ion-pairing agent concentration

Ion-Exchange HPLC (IEX)

Separates based on charge. Useful for:

• Removing truncated sequences (different net charge)
• Separating diastereomers
• Purifying very hydrophobic peptides

2. Column Selection

Stationary Phase Comparison

Phase	Particle Size	Pore Size	Best For
C18	3.5–5 µm	100 Å	Small peptides (<30 aa)
C18	5 µm	300 Å	Large peptides (>30 aa)
C8	3.5–5 µm	100 Å	Moderate hydrophobicity
C4	5 µm	300 Å	Membrane proteins, hydrophobic
Phenyl-hexyl	5 µm	100 Å	Aromatic separation
BEH Amide (HILIC)	1.7 µm	130 Å	Polar peptides, glycopeptides

Column Dimensions

Scale	Length	ID	Flow Rate	Loading
Analytical	150 mm	4.6 mm	1 mL/min	0.1–1 mg
Semi-prep	250 mm	10 mm	4–5 mL/min	5–20 mg
Preparative	250 mm	21.2 mm	10–20 mL/min	50–200 mg
Production	250 mm	50 mm	50–100 mL/min	0.5–5 g

Recommended Columns

• Analytics: Waters BEH C18, 1.7 µm, 2.1 × 150 mm
• Prep: Agilent Zorbax SB-C18, 5 µm, 21.2 × 250 mm
• Budget: Phenomenex Gemini C18, 5 µm, 21.1 × 250 mm

3. Mobile Phase Composition

Common Mobile Phases

System	Solvent A	Solvent B	Application
TFA/MeCN	0.1% TFA/H₂O	0.1% TFA/MeCN	Standard peptides
FA/MeCN	0.1% FA/H₂O	0.1% FA/MeCN	LC-MS compatible
NH₄OAc/MeCN	10 mM NH₄OAc/H₂O	10 mM NH₄OAc/MeCN	IC separation
Phosphate/MeCN	20 mM NaH₂PO₄/H₂O	MeCN	Ion-exchange

Ion-Pairing Agent Comparison

Agent	Concentration	Effect on Separation
TFA	0.05–0.1%	Strong ion-pairing, sharp peaks
FA	0.1%	Weak ion-pairing, MS-compatible
Heptafluorobutyric acid	0.05–0.1%	Very strong, for very polar peptides
NH₄OAc	10–20 mM	Volatile, good MS compatibility

4. Gradient Optimization

Initial Screening Gradient

Start with a broad gradient to identify the elution window:

Time (min)	%B
0	10
5	10
45	90
50	90
51	10
60	10

Gradient Steepness Optimization

The gradient slope (Δ%B per column volume) affects resolution:

• Shallow gradient (0.5–1% B/CV): Best resolution, longer run time
• Standard gradient (2–3% B/CV): Good balance
• Steep gradient (5–10% B/CV): Fast, lower resolution

Rule of thumb: For baseline resolution of two peaks differing by 1% B, use a gradient of <2% B per column volume.

Column Volume Calculation

Where r = column radius (cm), L = column length (cm), ε = column void fraction (~0.65 for fully porous silica).

For a 250 × 21.2 mm column: CV ≈ 57 mL

Optimization Example

Problem: Two peaks co-elute at ~55% B in 40 min gradient.

Solution:

1. Narrow the gradient around 50–60% B
2. Extend gradient over 60 min in this region
3. Reduce flow rate from 20 to 15 mL/min
4. Increase temperature from 25 to 40°C

5. Method Development Workflow

Step 1: Solubility Assessment

Before HPLC, ensure peptide is soluble in starting conditions:

1. Dissolve 1 mg peptide in 100 µL Solvent A
2. If insoluble, try: 50% MeOH, 1% FA, 10 mM NH₄HCO₃, or 6 M GuHCl
3. Filter through 0.45 µm syringe filter

Step 2: Analytical Run

Run analytical HPLC to:

• Determine elution window (%B at which peptide elutes)
• Identify major impurities (deletion sequences, truncated)
• Assess overall purity of crude material

Step 3: Preparative Method Development

Based on analytical results:

Crude Purity	Gradient	Loading
>80%	30–70% B over 40 min	100 mg/column
60–80%	20–60% B over 60 min	50 mg/column
<60%	10–50% B over 80 min	25 mg/column

Step 4: Fraction Collection

Strategy A — Peak-based: Collect fractions at each UV maximum Strategy B — Time-based: Collect every 30–60 seconds across the peak Strategy C — Threshold-based: Collect when UV > 50% of peak maximum

Recommended: Combine strategies A and C. Collect across the entire peak but pool only fractions >90% pure by analytical check.

6. Purification Strategies for Difficult Peptides

Hydrophobic Peptides (>40% hydrophobic residues)

• Use TFA/MeCN with 5% DMSO in Solvent A
• Add 0.1% TFA to both phases (sharpen peaks)
• Consider HILIC for very hydrophobic sequences

Hydrophilic Peptides (<20% hydrophobic residues)

• Use FA/MeCN system
• Consider HILIC mode (amide column)
• Add 10% MeOH to Solvent A to increase retention

Very Long Peptides (>50 residues)

• Use C18, 300 Å pore, 5 µm particles
• Low loading (10–20 mg/column)
• Shallow gradient (1% B/CV)
• Consider orthogonal purification (IEX then RP-HPLC)

Cysteine-Containing Peptides

• Add 1 mM EDT to mobile phases
• Keep temperature <25°C
• Consider TCEP in Solvent A (0.5 mM) to prevent oxidation

7. Fraction Analysis and Pooling

Analytical QC

1. Take 10 µL from each fraction
2. Dilute to 1 mL with 50% MeOH/0.1% FA
3. Inject 5 µL on analytical column
4. Run 5 min isocratic at 50% B, then gradient to 90% B

Pooling Criteria

Parameter	Acceptance	Action if Failed
Purity (UV220)	≥95%	Re-purify or pool selectively
Purity (UV280)	≥90%	Check Trp/Tyr content
Mass (MS)	Within 2 Da	Check for modification
Visual	Clear/colorless	Re-purify if colored

Second-Dimension Purification

If first-dimension purity is 80–95%, consider:

1. Ion-exchange: Separate by charge (removes deletion sequences)
2. HILIC: Separate by polarity (orthogonal to RP)
3. Size-exclusion: Remove aggregates

8. System Maintenance

Column Care

• Storage: 80% MeCN/H₂O (no TFA for C18 columns)
• Wash: After each use, flush with 95% MeCN for 10 CV
• Temperature: Never exceed 60°C
• Backpressure: Monitor; replace column if >80% of new-column pressure

Solvent Preparation

• Filter all mobile phases through 0.22 µm PVDF
• Degas by vacuum or helium sparging
• Prepare fresh daily for optimal reproducibility

References

1. Aguilar, M.-I. (Ed.). HPLC of Peptides and Proteins. Methods in Molecular Biology, Vol. 251. Humana Press, 2004.
2. Simpson, R.J. Purifying Proteins for Proteomics: A Laboratory Manual. Cold Spring Harbor Laboratory Press, 2004.
3. Stahl, G.L., et al. “Practical HPLC purification of synthetic peptides.” Journal of Peptide Science 14 (2008): 1–14.

Further Reading

• Purification Methods — Overview of all purification techniques
• Mass Spectrometry — Post-purification analysis
• Quality Control — Full QC panel